Death squads enlisted by the tumour suppressor p53

被引：97
作者：
Michalak, E
Villunger, A
Erlacher, M
Strasser, A [1 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[2] Innsbruck Med Univ, Bioctr, Div Pathophysiol, Innsbruck, Austria
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2005年 / 331卷 / 03期
基金：
美国国家卫生研究院; 英国医学研究理事会; 奥地利科学基金会;
关键词：
apoptosis; p53; cancer; PUMA; Noxa; BCL-2;
D O I：
10.1016/j.bbrc.2005.03.183
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
p53 is a tumour suppressor that is found mutated or functionally inactivated in more than half of all human cancers. p53 function is activated by DNA damage, hypoxia, expression of certain oncogenes, and many cytotoxic stimuli. p53 is a transcription factor that regulates expression of target genes which promote apoptotic cell death, cell cycle arrest.. cellular senescence, and some other processes. In this review we summarise current knowledge of p53 target genes implicated in apoptosis signalling. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：786 / 798
页数：13
相关论文
共 138 条
  • [1] Identification of SCN3B as a novel p53-inducible proapoptotic gene
    Adachi, K
    Toyota, M
    Sasaki, Y
    Yamashita, T
    Ishida, S
    Ohe-Toyota, M
    Maruyama, R
    Hinoda, Y
    Saito, T
    Imai, K
    Kudo, R
    Tokino, T
    [J]. ONCOGENE, 2004, 23 (47) : 7791 - 7798
  • [2] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [3] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [4] Attardi LD, 2000, GENE DEV, V14, P704
  • [5] Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis
    Attardi, LD
    Lowe, SW
    Brugarolas, J
    Jacks, T
    [J]. EMBO JOURNAL, 1996, 15 (14) : 3693 - 3701
  • [6] Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
    Bennett, M
    Macdonald, K
    Chan, SW
    Luzio, JP
    Simari, R
    Weissberg, P
    [J]. SCIENCE, 1998, 282 (5387) : 290 - 293
  • [7] Wip-ing out cancer
    Bernards, R
    [J]. NATURE GENETICS, 2004, 36 (04) : 319 - 320
  • [8] A large-scale RNAi screen in human cells identifies new components of the p53 pathway
    Berns, K
    Hijmans, EM
    Mullenders, J
    Brummelkamp, TR
    Velds, A
    Heimerikx, M
    Kerkhoven, RM
    Madiredjo, M
    Nijkamp, W
    Weigelt, B
    Agami, R
    Ge, W
    Cavet, G
    Linsley, PS
    Beijersbergen, RL
    Bernards, R
    [J]. NATURE, 2004, 428 (6981) : 431 - 437
  • [9] Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist bim
    Bouillet, P
    Cory, S
    Zhang, LC
    Strasser, A
    Adams, JM
    [J]. DEVELOPMENTAL CELL, 2001, 1 (05) : 645 - 653
  • [10] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738
12345678910